Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Παρόμοια τεκμήρια

• Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2002)
• Zoledronic acid prevents the development of myeloma bone disease and increases survival
  ανά: Shipman, C, κ.ά.
  Έκδοση: (2002)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2001)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2001)
• Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
  ανά: Croucher, P, κ.ά.
  Έκδοση: (2003)